Rubix LS announces today that it’s launching their therapeutics division.
Rubix LS Launches Therapeutics Division
read more
To truly close the gap of health inequities in therapeutic outcomes, we’re creating and utilizing platforms that propel us to become proactive in our therapeutic quest for science and discovery to treat every patient.
The tech that we’re powered by.
Virtual Clinical Trials
A system in which the patient can participate in clinical research within given approved health conditions from their couch.
Programmatic Therapeutics
Using designed therapies to focus on their overall increased outcomes for better care.
Blockchain
Heuristic Models
Scope of Services
With tools at our disposal, we’re supporting and delivering services for life science companies to overcome their challenges.
R&D
- Drug Development Strategies (i.e Fast Track, Breakthrough and etc)
- Medical Device Development Strategies
- Technology Transfer
- Formulation Development
- ADME & DMPK
- Process Scale-Up
- Process Validation
- Design V&V
- Particle Engineering
- Reverse Post-Mortem Engineering
- Etiological Effective Design
Clinical
- Pre-clinical development support
- Laboratory work
- Clinical Site Targeting
- Clinical Site Commissioning
- Targeted Patient Recruitment
- Clinical Trial Safety
- Patient Education & Engagement
- Siteless Trial Servicing and Logistics
- Whole Clinical Trial Phase Support
Regulatory & Quality
- Medical Device
- Drug-Device Combination Products
- Biologics
- Laboratory
- Generics
- Specialty Pharmaceuticals
- Xenotransplantation
- Software & Digital Health
Data Analytics
- Bioinformatics
- Biostatistics
- Pharmacogenomics
- Disease Prevalence Factors
- Disease Causation
- Virological Intelligence
- Environmental to Human linkage factors
- And more…
Medical Expertise
Working in regions across the globe, we’ve come to understand specific disease disciplines very well and work hard to support a growing number of organizations on the viability of effective research outcomes.
Infectious Disease
Ultra Rare Disease
Rare Disease
Neglected, Unknown, and Environmental Diseases
Notable Projects
SARS-CoV-2 (COVID-19)
Zika
Leishmaniasis
Nipah
Cholera
Hemorrhagic Fever
Latest News & Articles
We’re 5 years old! What we’ve done to date and what we’re going to do next.
Rubix LS Closes Seed Round for $1.25M
Rubix LS secures seed funding for $1.25M